Cephadol是日本药(相当于国产眩晕停——译者),能改善椎基底系统的血循,减轻血管痉挛,在前庭核及下丘水平阻断来自前庭分析器外周部分的病理性刺激,对血压几无影响。与抗组织胺类药和镇静剂不同,它对前庭核平面以上的中枢神经系不产生影响,故被广泛推荐用以治疗前庭外周性眩晕(美尼尔氏病、前庭神经元炎等);其禁忌症为严重的肾功能紊乱和药物过敏。临床使用含0.25mg盐酸diphenidol的片剂,根据症状轻重,日量3～6片。作者用以治疗21例美尼尔氏病及5名患弥漫性迷路炎后的患者(男11,女15;30～60岁;病程1.5～15年;9例伴有无症状的颈椎病,3例暂时性高血压、2例脑外伤后遗症,3例植物神经 Cephadol, a Japanese medicine that improves blood circulation in vertebrobasilar systems and reduces vasospasm, blocks pathological stimulation from the vestibular analyzer’s peripheral portion at the vestibular nucleus and inferior colliculus No effect on blood pressure. It is widely recommended for the treatment of vestibular peripheral vertigo (Meniere’s disease, vestibular neuritis, etc.), which is different from antihistamines and sedatives and does not affect the central nervous system above the vestibular nucleus. Contraindications for severe renal dysfunction and drug allergy. Clinical use of diphenidol hydrochloride tablets containing 0.25mg, according to the severity of symptoms, the daily dose of 3 to 6 tablets. The authors used to treat 21 patients with Meniere’s disease and 5 patients with diffuse labyrinthitis (male 11, female 15; 30 to 60 years; duration 1.5 to 15 years; 9 patients with asymptomatic cervical spondylosis, 3 cases of transient hypertension, 2 cases of traumatic brain injury sequelae, 3 cases of autonomic nerve